申请人:Merck Sharp & Dohme Corp.
公开号:US20200113924A1
公开(公告)日:2020-04-16
Therapies comprising administering at least one cyclic dinucleotide compound that activates the Stimulator of Interferon Genes (STING) pathway, and the use of such therapies in the treatment of cell-proliferation disorders such as cancer, are disclosed herein.